Tennis elbow
Drug research and approvals for tennis elbow: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 32 studies of tennis elbow are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 32
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Effect of Ultrasound-Guided Posterior Cutaneous Nerve of the Forearm Epicondylar Branch Block on Pain and Function in…NCT07894718 · Not applicable · Gaziler Physical Medicine and Rehabilitation Education and Research Hospital · starts Oct 25, 2025
- Central Sensitization and Ultrasound in Lateral EpicondylitisNCT07827898 · Not reported · Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · starts Aug 15, 2026
- A Comparison of the Effects of Combining ESWT With Blood Flow Restriction Therapy in Patients Diagnosed With Lateral…NCT07782723 · Not applicable · Ankara Yildirim Beyazıt University · starts Apr 3, 2025
- The Effect of Multimodal Approach of Electrotherapy Versus Shock Wave Therapy in Menopausal Women With Tennis Elbow.NCT07750080 · Not applicable · October 6 University · starts Mar 3, 2026
- Autologous Fat Grafting for the Treatment of Chronic TendinopathyNCT07748793 · Not applicable · Weill Medical College of Cornell University · starts Oct 31, 2026
- Illness Perception and Treatment Expectations in Lateral Elbow PainNCT07722845 · Not reported · Acibadem University · starts Nov 13, 2026
- Evaluation of the Effectiveness of Capacitive and Resistive Energy Transfer Therapy for Lateral EpicondylitisNCT07634224 · Not applicable · Gaziantep City Hospital · starts May 11, 2026
- Wrist Heavy Slow Resistance and Shoulder Stabilization Exercises on Pain, Grip Strength and Functional Ability in…NCT07576829 · Not applicable · University of Faisalabad · starts Feb 2, 2026
- Comparison of Extracorporeal Shock Wave Therapy and Low-Level Laser Therapy in Patients With Lateral EpicondylitisNCT07564713 · Not applicable · Hitit University · starts May 4, 2026
Approved 4
- Triamcinolone acetonideGlucocorticoid receptor agonist
- DexamethasoneGlucocorticoid receptor agonist
- PrednisoneGlucocorticoid receptor agonist
- Dexamethasone phosphoric acidGlucocorticoid receptor agonist
Phase 3 4
- Dextrose
- OnabotulinumtoxinaSynaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- AbobotulinumtoxinaSynaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
- LidocaineSodium channel alpha subunit blocker
Phase 2 6
- Methylprednisolone acetateGlucocorticoid receptor agonist
- PiroxicamCyclooxygenase inhibitor
- Betamethasone phosphoric acidGlucocorticoid receptor agonist
- CapsaicinVanilloid receptor opener
- Polidocanol
- Fibrin
Phase 1 or earlier 1
- DoxycyclineMatrix metalloproteinase 7 inhibitor
How its trials ended
223 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 27 whose ending is known, 41% met their primary endpoint, 7% missed it and 52% stopped early.
- Completed, result not reported10848%
- Ongoing4520%
- Status unknown4319%
- Met its primary endpoint115%
- Stopped: other or unclear84%
- Stopped: enrollment or feasibility42%
- Missed its primary endpoint21%
- Stopped: lack of efficacy1<1%
- Stopped: sponsor or business decision1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA